EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Oat β‐Glucan and Galactooligosaccharides Influence Gallstone Formation by Modulating the Gut Microbiota, Particularly Desulfovibrionales

Liang Tian, Yanyan Lin, Ping Yue, Long Gao, Leiqing Wang, Chongfei Huang, Jinyu Zhao, Ningzu Jiang, Jiahui xi, Haidong Ma, Zhen Liu, Ruyang Zhong, Wenkang Fu, Ningning Mi, Mingzhen Bai, Bodong Zhang, Lunzhi Dai, Jiang Li, Hu Chen, Jinqiu Yuan, Wenbo Meng

iMetaMed · 2026-03 · 2 (1)

DOI: 10.1002/imm3.70029 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Cholesterol gallstone disease is a prevalent ailment of the digestive system, accumulating evidence indicates a significant association between gut flora and gallstone formation. In the present research, we found that oat β‐glucan promotes gallstone formation, whereas galactooligosaccharides exerted inhibitory effects. Notably, these opposing effects were neutralized upon co‐administration of both prebiotics. Further research demonstrated that both prebiotics act primarily through modulating the abundance of Desulfovibrionales. The metabolic product of Desulfovibrionales, H 2 S, can directly activate the hepatic farnesoid X receptor (FXR) and thereby suppress bile acid production via FXR‐SHP signaling. Additionally, H 2 S can increase secondary bile acid levels (DCA, LCA) by promoting intestinal 7α‐dehydroxylase function. These secondary bile acids further decrease bile acid production in the liver via the intestinal FXR‐FGF15 cascade. Moreover, the upregulated production of secondary bile acids also enhances bile hydrophobicity. Collectively, these effects induce biliary cholesterol overloading, and ultimately promote gallstone formation. Our findings elucidate the effect of oat β‐glucan and galactooligosaccharides on gallstone formation, and suggest that alterations in Desulfovibrionales abundance and its influence on hepatic FXR‐SHP and intestinal FXR‐FGF15 pathways may underlie the potential mechanisms.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →